BerGenBio ASA was a clinical-stage biopharmaceutical company based in Bergen, Norway, focused on developing first-in-class AXL inhibitors before completing a merger to become…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see BerGenBio ASA →Already a subscriber? Sign in
Xcout Intel tracks BerGenBio ASA continuously — this profile deepens as new filings, funding, people and hiring data arrive.